Inhibitor Report for: Lalistat-alkyne-probe General
Type Piperidine , Lipase inhibitor , Sulfur compound , Thiadiazol , Alkyne Chemical_Nomenclature (4-piperidin-1-yl-1,2,5-thiadiazol-3-yl) 4-ethynylpiperidine-1-carboxylate Canonical SMILES C#CC1CCN(CC1)C(=O)OC2=NSN=C2N3CCCCC3 InChI InChI=1S/C15H20N4O2S/c1-2-12-6-10-19(11-7-12)15(20)21-14-13(16-22-17-14)18-8-4-3-5-9-18/h1,12H,3-11H2 InChIKey VAEZZLHMRMPXQR-UHFFFAOYSA-N Other name(s) lalistat probe La-1 ; La-1 ; CHEMBL4104095 ; SCHEMBL19584717 ; J3.628.567B ; 4-Ethynyl-1-piperidinecarboxylic acid 3-(1-piperidinyl)-1,2,5-thiadiazole-4-yl ester
________________________________________________________________________________________________
References:
Title: Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases
Davda D , Martin BR
Ref: Medchemcomm, 7 :1797, 2016 : PubMed Abstract ESTHER: Lehmann_2016_Medchemcomm_7_1797 PubMedSearch: Lehmann 2016 Medchemcomm 7 1797 Gene_locus related to this paper: myctu-Rv3084 Inhibitor(s) related to this paper: Lalistat-alkyne-probe ,
Lalistat-1 ,
Lalistat-2 Abstract
Lalistat inhibits growth of Mycobacterium tuberculosis in bacterial culture as well as in infected macrophages. Target identification by quantitative proteomics revealed a cluster of 20 hydrolytic proteins including members of the lipase family. Lipases are essential for M. tuberculosis fatty acid production and energy
storage thus representing promising antibiotic targets.